MAPT and Hyperglycemia: It has been found that low-dose STZ-induced hyperglycemia impairs network activity in the hippocampus and anterior cingulate cortex, mainly by increasing the phosphorylation of tau in the hippocampus and cortex (Wirt et al., 2021).